New York Senate Cannabis Committee Invites People To Apply To Testify At Hearing On Legalization Challenges This Month
The chair of a New York Senate cannabis committee is inviting members of the public
Number of the Week: 54%
54% – Percentage of Republican cannabis consumers who use the products multiple times a day
India Carves Out Its Own Lane in the Shroom Boom
The first mushroom festival in India took place September 15-18 in the verdant and fungally
Canopy, Tilray Close Deals as One Shrinks and the Other Grows
Today’s transaction closings really sum up the current cannabis industry. One company is shedding assets
Physician Advocacy Group Adopts New Name To Reflect Growing Focus On ‘Drug Policy Issues Beyond Cannabis’
The physician advocacy group long known as Doctors for Cannabis Regulation (DFCR) has rebranded itself
Cannabis banking amendment details (Newsletter: October 2, 2023)
German legalization advances; MI marijuana testing change; Nurses group recognizes cannabis; SD ballot dispute; NJ
MediPharm Settles $9M Dispute with HEXO, Establishes New Deal with Tilray
Tilray’s acquisition of HEXO opened up new dialogue. Toronto-based MediPharm (TSX: LABS) (OTCQX: MEDIF) announced
A Lawyer Is Suing The Feds For A Copy Of The Biden Administration’s Marijuana Rescheduling Letter
A federal lawsuit is stepping up pressure on the U.S. Health and Human Services Department
A weed hangover? Why Thailand’s having second thoughts about decriminalizing cannabis
Opening a cannabis dispensary wasn’t always top of the list of Wassaya Iemvijan’s ambitions. The
Mass. cannabis commission chair sues state treasurer over suspension
Shannon O’Brien, the suspended chair of the Cannabis Control Commission, filed a lawsuit Thursday against